Prosecution Insights
Last updated: April 19, 2026

Mccarter & English, LLP Wilmington

17 pending office actions • 14 clients

Portfolio Summary

17
Total Pending OAs
6
Final Rejections
11
Non-Final OAs

Client Portfolio (14 clients)

Client (Assignee)Pending OAs
Highspot, Inc. 3
Alachua Government Services, Inc. 2
Christiana Care Gene Editing Institute, Inc. 1
Productos Farmaceuticos, S.A. De C.V. 1
Ddp Specialty Electronic Materials US, LLC 1
Arkion Life Sciences, LLC 1
Fundacion De La Comunitat Valenciana Para La Gestion Del Instituto De Investigacion Sanitaria 1
Consorcio Centro De Investigación Biomédica En Red 1
The Regents of the University of California 1
UNIVERSIDAD DE GRANADA 1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS 1
Icm (Institut De Cancerologie De Montpellier) 1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS 1
Yamaguchi University 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18919303 EVALUATING TOPIC TREATMENT IN ELECTRONIC COMMUNICATIONS Highspot, Inc. MISIASZEK, AMBER ALTSCHUL 3682 Final Rejection Oct 17, 2024
18679206 USING LARGE LANGUAGE MODEL-GENERATED DESCRIPTIONS IN A CONTENT REPOSITORY Highspot, Inc. LEE, JANGWOEN 2656 Non-Final OA May 30, 2024
18679231 USING LARGE LANGUAGE MODELS TO GENERATE ELECTRONIC MESSAGES ASSOCIATED WITH CONTENT ITEMS Highspot, Inc. LEE, EUNICE SOMIN 2656 Non-Final OA May 30, 2024
18711261 METHODS FOR INTRATUMORAL DELIVERY OF CRISPR/CAS SYSTEMS Christiana Care Gene Editing Institute, Inc. ALLEY, GENEVIEVE S 1617 Non-Final OA May 17, 2024
18512349 DROPROPIZINE IN COMBINATION WITH AMBROXOL IN THE DOSAGE FORM OF SYRUP AND TABLETS Productos Farmaceuticos, S.A. De C.V. SAEED, ALI S 1616 Final Rejection Nov 17, 2023
18482064 System For Determining Construction Installation Accuracy Ddp Specialty Electronic Materials US, LLC SANTOS, DANIEL JOSEPH 2667 Final Rejection Oct 06, 2023
18223654 TRIGEMINAL CUE FOR WILDLIFE REPELLENTS Arkion Life Sciences, LLC CHAO, ALLEN 1622 Non-Final OA Jul 19, 2023
18246742 MEMORY T CELLS AS ADOPTIVE CELL THERAPY FOR VIRAL INFECTIONS Fundacion De La Comunitat Valenciana Para La Gestion Del Instituto De Investigacion Sanitaria STAVROU, CONSTANTINA E 1632 Non-Final OA Mar 27, 2023
18025074 MESENCHYMAL STEM CELLS CO-EXPRESSING CXCR4 AND IL-10 AND USES THEREOF Consorcio Centro De Investigación Biomédica En Red VIJAYARAGHAVAN, JAGAMYA NMN 1633 Non-Final OA Mar 07, 2023
18116963 BIOMARKERS FOR IDENTIFYING MPMRI VISABLE TUMOURS AND ASSESSING TUMOUR AGGRESSIVENESS OF PROSTATE CANCER The Regents of the University of California ALABI, OYELEYE A 1797 Non-Final OA Mar 03, 2023
18020293 DEVICE FOR THE PRODUCTION, MODERATION AND CONFIGURATION OF NEUTRON BEAMS FOR NEUTRON CAPTURE THERAPY UNIVERSIDAD DE GRANADA STOFFA, WYATT A 2881 Final Rejection Feb 08, 2023
18019397 BIOSENSOR SYSTEM FOR MULTIPLEXED DETECTION OF BIOMARKERS CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS LYLE, SOPHIA YUAN 1796 Non-Final OA Feb 02, 2023
18018687 ARMED NK CELLS FOR UNIVERSAL CELL THERAPY Icm (Institut De Cancerologie De Montpellier) SWARTWOUT, BRIANNA KENDALL 1644 Non-Final OA Jan 30, 2023
18008938 Assay for the detection of the Cys-like protease (Mpro) of SARS-CoV-2 CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS PARKIN, JEFFREY S 1671 Non-Final OA Dec 07, 2022
17561389 METHOD FOR CULTIVATION OF ADHERENT CELLS IN A MULTIPARALLEL BIOREACTOR Alachua Government Services, Inc. HUMPHRIES, NICHOLAS ADAM 1631 Final Rejection Dec 23, 2021
17310390 METHOD FOR VIRUS PRODUCTION Alachua Government Services, Inc. BUCKMASTER, MARLENE VRENI 1672 Final Rejection Jul 30, 2021
16625877 KIT FOR EVALUATING GENE MUTATION RELATED TO MYELOPROLIFERATIVE TUMOR Yamaguchi University SALMON, KATHERINE D 1682 Non-Final OA Dec 23, 2019

Managing Mccarter & English, LLP Wilmington's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month